Development of Metal Complexes with Antidialetic Effect
Development of Metal Complexes with Antidialetic Effect
批准号:
16001003
负责人:
SAKURAI Hiromu
金额:
$86.61万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Specially Promoted Research
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Diabetes mellitus (DM) with a common pathogenesis of hyperglycemia is classified into two types; insulin-dependent type 1 DM characterized by the absence of insulin synthesis and secretion in the pancreas, and non-insulin-dependent type 2 DM characterized by insulin resistance due to obesity.The former is treated only by daily insulin injections and the latter needs exercise and diet control along with the administration of oral synthetic medicines. Daily insulin injections are associated with physical and spiritual burden, and, in addition, the long-term insulin injections leads to the formation of self-antibodies in some patients. The administration of oral medicines causes the pancreas to discontinue insulin synthesis because of a reduced insulin demand. This in turn necessitates the need for insulin injections. In order to overcome the defects of insulin injections and oral medicines, we have planed to develop new antidiabetic agents with a novel mechanism of action. For this purpose, we used metal complexes to treat both types of DM in experimental animals. On the basis of the results, we found the followng facts. (1) A new in vitro evaluation system was established in terms of glucose uptake and inhibition of free fatty acid release in the adipocytes, (2) In vanadyl (+4)-picolinate complexes, the importance of the substituent position rather than the electronic effect was conclude to enhance the hypoglycemic activity of the complexes. (3) In the study on structure-activity relationship for vanadyl- and zinc-3-hydroxypyrone complexes, excellent allixin-related complexes, which improve not only antidiabetic state but also anti-metabolic syndromes, were found, (4) The complexes have been revealed to act on the insulin signaling cascade, and finally to transport the glucose transporter 4 in the cell membranes, and (5) Some drug delivery systems were proposed for vanadyl compounds. From these facts, several complexes for clinical trials in the future were proposed.
期刊论文(161)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.jinorgbio.2006.12.015
发表时间:
2007-04-01
期刊:
JOURNAL OF INORGANIC BIOCHEMISTRY
影响因子:
3.9
作者:
[Basuki, Wanny, Hiromura, Makoto, Sakurai, Hiromu]
通讯作者:
Sakurai, Hiromu
A family of insulinomimetic zinc(II) complexes of amino ligands with Zn(Nn) (n=3 and 4) coordination modes
具有 Zn(Nn)(n=3 和 4)配位模式的氨基配体的类胰岛素锌 (II) 配合物家族
DOI:
--
发表时间:
2005
期刊:
J. Inorg. Biochem. 99・7
影响因子:
--
作者:
[ZEUS Collaboration, S.Chekanov, et al., Yutaka Yoshikawa]
通讯作者:
Yutaka Yoshikawa
糖尿病・メタボリックシンドロームを治す金属錯体の開発研究
治疗糖尿病和代谢综合征的金属配合物的研发
DOI:
--
发表时间:
2007
期刊:
化学 62・3
影响因子:
--
作者:
[A.Suzuki (24/82), K.Inoue (8/82), J.Shirai (21/82), M.Koga (11/82), T.Mitsui (14/82), Y.Kishimoto (10/82), (KamLAND collaboration), 桜井 弘]
通讯作者:
桜井 弘
Metals in medicines-treatment of diabetes mellitus
药物中的金属——治疗糖尿病
DOI:
--
发表时间:
2007
期刊:
Kinzoku 77(3)
影响因子:
--
作者:
[S. Maeda, S. Nakagawa, M. Suga, E. Yamashita, A. Oshima, Y. Fujiyoshi and T. Tsukihara, Hiromu Sakurai]
通讯作者:
Hiromu Sakurai
Oxovanadium(IV) and (V) complexes with 3-hydroxy-4(1H)-pyridinones and 1-hydroxy-2(1H)-pyrimidinones-synthesis, structural characteristics, and their insulin-mimetic activities
氧钒 (IV) 和 (V) 与 3-羟基-4(1H)-吡啶酮和 1-羟基-2(1H)-嘧啶酮的配合物的合成、结构特征及其胰岛素模拟活性
DOI:
--
发表时间:
2006
期刊:
Biomed. Res. Trace Elements 17・1
影响因子:
--
作者:
[H. Suzuki, K. Nishikawa, Y. Hiroaki and Y. Fujiyoshi, T.Araki et al., A Oshima, T.Araki et al., S. Hayakawa, Mika Yamaguchi, H. Suzuki, K.Inoue, Pabla Noblia, Y. Yukutake, Akira Katoh]
通讯作者:
Akira Katoh
共 95 条
Research and Development of Protective Compounds against UV Iight-induced Skin Damage on the Basis of anti-ROS properties
-
批准号:11793015
-
项目类别:Grant-in-Aid for University and Society Collaboration
-
资助金额:$3.71万
-
财政年份:1999
-
负责人:SAKURAI Hiromu
-
依托单位:
Studies on orally active antidiabetic vanadium complexes with low toxicity and long-term action
-
批准号:08457622
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.67万
-
财政年份:1996
-
负责人:SAKURAI Hiromu
-
依托单位:
ESR studies on biological free radicals in pharmaceutical sciences
-
批准号:07307036
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$2.11万
-
财政年份:1995
-
负责人:SAKURAI Hiromu
-
依托单位:
Study on bioinorganic chemistry for the mechanism of the development of hapatitis-hepatoma in LEC rats
-
批准号:06672157
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1994
-
负责人:SAKURAI Hiromu
-
依托单位:
Bioinorganic Chemistry on Vanadium Complexes possessing Anti-diabetic Action
-
批准号:02670982
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1990
-
负责人:SAKURAI Hiromu
-
依托单位:
海外基金